Palmitoylated SARM1 targeting P4HA1 promotes collagen deposition and myocardial fibrosis: A new target for anti-myocardial fibrosis
Authors:
Open Access
- 15 July 2025
- journal article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 15 (9) , 4789-4806
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82370417)
- National Natural Science Foundation of China (82330011)
- National Natural Science Foundation of China (U21A20339)
- National Natural Science Foundation of China (82270273)
- Science Fund for Distinguished Young Scholars of Heilongjiang Province
- Natural Science Foundation of Heilongjiang Province (JQ2024H001)
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine (2020-I2M-5-003)
This publication has 54 references indexed in Scilit:
- Multilevel chitosan–gelatin particles loaded with P4HA1 siRNA suppress glioma developmentDrug Delivery and Translational Research, 2023
- Protein palmitoylation in cancer: molecular functions and therapeutic potentialMolecular Oncology, 2022
- The therapeutic potential of berberine chloride against SARM1‐dependent axon degeneration in acrylamide‐induced neuropathyPhytotherapy Research, 2022
- MET-Targeted Therapies and Clinical Outcomes: A Systematic Literature ReviewMolecular Diagnosis & Therapy, 2022
- Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunitiesAdvanced Drug Delivery Reviews, 2021
- Artemisinin and artemisinin derivatives as anti-fibrotic therapeuticsActa Pharmaceutica Sinica B, 2021
- Heart Failure After Myocardial Infarction: Incidence and PredictorsESC Heart Failure, 2020
- Protein palmitoylation and its pathophysiological relevanceJournal of Cellular Physiology, 2020
- Epidemiology of Heart FailureEuropean Journal of Heart Failure, 2020
- HIF‐1α interacts with Kindlin‐2 and influences breast cancer elasticity: A study based on shear wave elastography imagingCancer Medicine, 2020